That'd be a shame 'cause
I'm the one who could feel the sun
Right in the pouring rain
--Lou Gramm
Interesting that Marc Faber brings up Johnson & Johnson (JNJ) in this interview as an investment likely to outperforrm many others (such as bonds) over the next 10 yrs. As he notes, this stock is not immune from price declines, but it's low beta and high yield make it an interesting prospective investment in the present environment.
Continue to like JNJ--prolly my favorite long term investment name. Wondering whether that 38% Fibo retracement level at $57-58 may not be in the cards. If so, then I hope to 'be there.'
position in JNJ
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)
1 comment:
During the last 37 calendar years, J&J stock has appreciated over 20% twelve times.
During the last 37 calendar years, J&J stock has never depreciated over 20%.
Post a Comment